Ohio State Medical Oncology
@OhioStateMedOnc
Followers
614
Following
1K
Media
215
Statuses
1K
The OSU Division of Medical Oncology: providing cutting-edge compassionate care through team science to those diagnosed with solid tumor malignancies
Columbus, OH, USA
Joined January 2023
Read more about a new clinical trial using a drug developed at @OSUCCC_James. JBZ-001 is licensed to a commercial partner, Jabez Biosciences, which is working with @AsrarAlahmadi, trial PI.
0
1
4
RT @jclinicalinvest: ICYMI: .Vaccines in cancer treatment and prevention: the time is now: . In this viewpoint, Wil….
0
4
0
📝New publication from Dr. Sameek Roychowdhury & colleagues: Prevalence and biological impact of clinically relevant gene fusions in head and neck cancers @Nature_NPJ .
0
3
12
👏Congrats, Dr. Hays! @OSUCCC_James.
We are pleased to announce John Hays, MD, PhD, as the new chair of our Steering Committee! .Learn more about his vision for the consortium:
0
0
6
📺@JKaufmanLungNED discusses clinical trials.
Dr. Jacob Kaufman shares how clinical trials can offer groundbreaking options when nothing else is left. Today’s research is tomorrow’s treatment. 🎥 Click to watch the full conversation: #LungCancerResearch #ClinicalTrials #LungCancer
0
1
2
📝New publication from @royaryam, @OSUCCC_James breast medical oncologist.
🚨Proud to share our publication in @JCOOP_ASCO .🧵International Medical Graduates (IMGs) are underrepresented in invited faculty roles at #ASCO Annual Meetings, despite their contributions to original research! @DrChoueiri @NazliDizman @ZiadBakouny @IMG_Oncologists @GlopesMd
0
1
5
📝New publication from Dr. David Carbone & colleagues: Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA @ESMO_Open @OSUCCC_James #NSCLC .
0
0
6
RT @DAVAOnc: Early-stage lung cancer detection strategy! Dr.@LoganRoofMD of @OSUWexMed details the Lung Nodule Clinic model—>60 lung cance….
0
7
0
RT @christinemphmd: “Old does not = frail.” Dr. Carolyn Presley @CPresGeriOncMD discusses the design of the ACHIEVE study, emphasizing the….
0
12
0
RT @Al3ssandroRusso: A great lecture of Prof. @ChristianRolfo at the #Fonicap consensus conference here at the International School of Medi….
0
9
0
RT @lungoncdoc: Dr. @LoganRoofMD reviews the development of the lung cancer screening program at @OSUCCC_James. A very important initiative….
0
4
0
RT @fra_drake: Huge congratulations to @RobertoBoreaMD the publication of a project started during his time at @UNC !.A great achievement a….
0
3
0
📝New publication from Dr. Steven Clinton & colleagues: Integration of genetic counselling into a multidisciplinary urological oncology programme enhances access and detection of hereditary prostate cancer syndromes.
0
0
4
🎉Congrats to Amir Mortazavi on his appointment to the honorary Mazzaferri-Ellison Society of Master Clinicians, which recognizes outstanding clinicians who excel in clinical practice, clinical teaching, mentoring/role modeling, professionalism, leadership & service to @OSUWexMed
1
2
19
📝New editorial from our head & neck cancer team: Novel combinations with programmed cell death 1 inhibitor for incurable recurrent/metastatic head and neck squamous cell carcinoma (RM HNSCC): is cabozantinib a front runner? .
0
0
2
RT @OSUCCC_James: World class lung cancer screening is ready to hit the road in Ohio, as Jasleen Pannu, MBBS, and colleagues cut the ribbon….
0
6
0
RT @ASCO: New #ASCOEdBook article: @dwightowenmd and @BenjaminBesseMD et al. review advances that led to the current standard of care for s….
0
3
0
📺Patient Power: Cancer Care for Older Adults: What You Need to Know featuring @CPresGeriOncMD #asco2025 .
1
3
6